Pharmaceutical Supply Chains

The generic drugs the US buys from India still start with Chinese feedstocks

A Foreign Affairs essay credits Beijing with escalation dominance built on 80 to 90 percent of rare-earth production, and argues that cutting direct imports from China has made American supply chains harder to trace.